Atreca, Inc. logo

Atreca, Inc.

25 employees · est. 2011 · South San Francisco, United...

VS
Eikon Therapeutics logo

Eikon Therapeutics

Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics

429 employees · est. 2019 · Millbrae, United States

Atreca, Inc. is the older company (2011 vs 2019); Eikon Therapeutics is the larger of the two.

Side-by-Side Comparison

Atreca, Inc. Eikon Therapeutics
Founded
2011 older 2019
Headquarters
South San Francisco, United States Millbrae, United States
Employees
25 429 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care, Life Sciences
Funding Stage
Post Ipo Equity Series D
Total Funding
$347.86M $1.12B
Funding Rounds
7 5
Services
Not tracked yet Therapeutics Development, Pipeline Advancement, Novel Target Identification, Data Analysis with Machine Learning
Target Customers
Not tracked yet Patients with Unmet Medical Needs, Healthcare Providers, Research Institutions
Taxonomy
Cancer Immunotherapy, Therapeutics, Immune Repertoire Capture, Clinical Outcomes, Immune Response, Cancer Research, Healthcare Innovation, Investment, Human Health, Scientific Innovation, Biopharmaceuticals, Biomedical Technology Biopharmaceutical, Clinical-stage, Therapeutics, Oncology, Immune Response Modulation, Synthetic Lethality, Single-molecule Imaging, Neurological Diseases, Machine Learning Algorithms, Imaging Data Analysis, Drug Discovery, Interdisciplinary Scientific Exploration, Molecular-resolution Imaging, Protein Movement Analysis, Innovative Therapeutic Development
Website
atreca.com eikontx.com
Atreca, Inc. logo

About Atreca, Inc.

Atreca, Inc. is a biotechnology company focused on developing novel therapeutics with a deep understanding of the human immune response, particularly in the field of innovative cancer immunotherapeutics. Founded in 2010, Atreca leverages its Immune Repertoire Capture™ (IRC™) technology to gain unpar...

Eikon Therapeutics logo

About Eikon Therapeutics

Eikon Therapeutics, founded in 2019, is a United States-based late-stage clinical biopharmaceutical company with a focus on inventing and developing breakthrough therapeutics. The company is advancing therapies for patients with unmet medical needs and employs cutting-edge technology such as single-...

We will tell you when either one moves

BounceWatch watches Atreca, Inc. and Eikon Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Atreca, Inc. and Eikon Therapeutics — by email.

Frequently Asked Questions

Atreca, Inc.. Eikon Therapeutics — Eikon is a late-stage clinical biopharmaceutical company dedicated to inventing and developing breakthrough therapeutics. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Atreca, Inc. has raised $347.86M while Eikon Therapeutics has raised $1.12B.
Atreca, Inc. and Eikon Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Atreca, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Atreca, Inc. on 12 Sep 2024, and Eikon Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes